EverQuote Boston Consulting Group Matrix
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
BCG Matrix: Clear Guidance for Product and Investment Decisions
This BCG Matrix snapshot places EverQuote's primary lead-generation products among Stars, Cash Cows, Question Marks, or Dogs as the insurtech market shifts, providing essential context for resource allocation and growth planning. The preview outlines likely market signals and strategic levers; the full BCG Matrix delivers quadrant-level analysis, data-supported recommendations, and editable Word and Excel deliverables to accelerate research and inform confident product or investment choices.
Stars
Auto Insurance Vertical
Auto Insurance Vertical: EverQuote's core growth engine, posting a 97% YoY revenue jump in Q1 2025 and sustained double-digit growth through 2025, driven by a 30%+ rebound in carrier ad spend and rising digital quote demand.
As the online leader in auto referrals with estimated 40%+ market share, its high growth and market dominance need heavy marketing reinvestment, matching the BCG Star profile.
Enterprise Carrier Channel
Revenue from large enterprise carriers rose over 27% in late 2025, driven by a healthy underwriting environment and the return of major national insurers to EverQuote's platform, lifting quarterly carrier revenue to roughly $85-90M.
EverQuote is now the number one customer-acquisition partner for at least one major national carrier, signaling a dominant market share in this fast-growing segment and supporting sustained pricing leverage.
Rapid expansion consumes cash; ongoing investment in AI-driven traffic acquisition-estimated at 10-15% of channel revenue-remains essential to scale growth and protect churn-sensitive ROAS.
AI-Powered Smart Campaigns
AI-Powered Smart Campaigns 3.0 delivers up to 20% immediate efficiency gains for carrier partners, marking EverQuote's shift to AI-driven growth products and driving revenue-per-lead improvements observed since rollout in Q3 2024.
Local Agent Network
The local agent channel is a Star: paid products per agent rose 15% year-over-year and over one-third of agents now buy multiple EverQuote offerings, signaling strong market pull toward bundled digital suites.
Agents are shifting from legacy lead-generation to full digital growth suites, creating high-growth revenue potential; EverQuote is investing heavily to seize online local agent ad spend, which grew ~12% in 2024 to $X.XXB.
- 15% rise in paid products/agent
- 33%+ agents using multiple products
- Segment aligns with 12% growth in local online ad spend (2024)
- Company increasing CAPEX and sales focus to expand share
Digital P&C Advertising Marketplace
Operating in a $117 billion P&C distribution TAM, EverQuote's Digital P&C Advertising Marketplace is a Star-supported by a 15% CAGR in digital ad spend and the platform's leading position connecting high-intent shoppers to providers, with ~30-40% of quoted leads traced to online channels in 2024.
EverQuote defends its moat by reinvesting ~18-22% of revenue into data science and traffic acquisition in 2024, countering emerging tech rivals and sustaining unit economics and lead quality.
- Market: $117B P&C distribution TAM
- Growth: 15% digital ad spend CAGR
- Share: ~30-40% leads from online channels (2024)
- Reinvestment: ~18-22% revenue into data & traffic (2024)
EverQuote: Auto Market Leader-97% YoY Growth, 40%+ Share, $85-90M Carrier Rev
EverQuote's Auto/Local agent channels are BCG Stars: 40%+ market share in auto referrals, 97% YoY auto revenue growth in Q1 2025, carrier quarterly revenue ~$85-90M, and reinvestment of ~18-22% revenue into AI/traffic to sustain a 15%+ digital ad CAGR and protect ROAS.
| Metric | Value |
|---|---|
| Auto YoY growth (Q1 2025) | 97% |
| Auto market share (est) | 40%+ |
| Carrier revenue (quarter) | $85-90M |
| Reinvestment in data/traffic (2024) | 18-22% |
| Digital ad spend CAGR | 15% |
What is included in the product
Detailed Word Document
Comprehensive BCG Matrix for EverQuote detailing Stars, Cash Cows, Question Marks, and Dogs with strategic investment guidance.
Customizable Excel Spreadsheet
One-page EverQuote BCG Matrix placing segments in quadrants for instant strategic clarity.
Cash Cows
Home and Renters Insurance Vertical
The home and renters insurance vertical delivered steady 15%-23% year-over-year growth through 2025, adding about $110 million in revenue that year and representing roughly 18% of EverQuote's total revenue. It sits as a mature cash cow with lower marketing spend-customer acquisition cost down ~12% vs. auto-and generates predictable free cash flow used to fund new product launches. This segment underwrites corporate operations and subsidizes expansion into higher-risk lines like commercial and specialty insurance.
Direct Channel Referral Fees
A majority of EverQuote's revenue comes from direct channel referral fees, a mature, high-margin stream that produced record Adjusted EBITDA in 2025-$120 million on revenue of $420 million (FY 2025).
Years of data and platform optimization have pushed referral fee margins above 45%, making the segment a reliable cash cow funding EverQuote's first $50 million share repurchase program launched in Q4 2025.
Established Carrier Partnerships
Established carrier partnerships generate steady recurring ad spend: EverQuote reported $226M revenue in 2024, with insurance-advertising a core contributor, and long-term ties to national and regional carriers reduce churn and sales costs versus new enterprise acquisition.
These mature relationships have low maintenance costs, so EverQuote can "milk" predictable cash flow to fund R&D; the company held roughly $150M cash and no net debt at FY2024 year-end, supporting ongoing product investment.
Proprietary Data and Technology Platform
EverQuote's proprietary data and tech platform has matured into a low – incremental – cost asset, processing 2024 volumes of ~18M consumer matches annually and driving gross profit margins above 40% in core insurance verticals.
By 2025 the matching precision-conversion lift ~28% versus industry leads-became a durable competitive advantage, producing recurring cash flow that funds growth and lowers CAC.
The same infrastructure supports mortgages, auto, and home services, leveraging initial R&D (capitalized ~ $120M through 2023) across verticals to maximize ROI.
- 2024: ~18M matches; gross margin >40%
- 2025: +28% conversion lift vs market leads
- R&D capex ~ $120M through 2023; multi-vertical reuse
Quote-Comparison Engine
The Quote-Comparison Engine is a mature, web-based core product serving ~6.5 million annual users in 2024, delivering steady high-intent traffic with a 3.8% conversion rate and low maintenance capex, making it a clear cash cow in EverQuote's BCG matrix.
Its annual EBITDA contribution of roughly $45-55 million in 2024 funds corporate overhead and bankrolls the firm's pivot to AI-powered lead scoring and personalization.
What this hides: growth is flat low-single digits, so cash reinvestment prioritizes AI R&D to sustain long-term relevance.
- 6.5M users (2024)
- 3.8% conversion rate
- $45-55M EBITDA (2024)
- Low maintenance capex; funds AI shift
EverQuote: $420M Revenue, $120M EBITDA - High-Margin Referral Cash Cow
EverQuote's insurance referral and quote-comparison assets are cash cows: FY2025 revenue ~ $420M with Adjusted EBITDA $120M, home/renters vertical ~$110M (18% revenue) growing 15-23% YoY, 2024 matches ~18M, referral margins >45%, conversion lift ~28% vs market, Quote-Comparison users 6.5M (2024) with 3.8% conversion and $45-55M EBITDA (2024).
| Metric | Value |
|---|---|
| FY2025 Revenue | $420M |
| Adjusted EBITDA (2025) | $120M |
| Home/Renters Rev (2025) | $110M (18%) |
| Matches (2024) | ~18M |
| Referral Margin | >45% |
| Conversion Lift | ~28% |
| Quote-Comparison Users (2024) | 6.5M |
| Quote-Comparison EBITDA (2024) | $45-55M |
What You See Is What You Get
EverQuote BCG Matrix
The file you're previewing is the exact, final EverQuote BCG Matrix report you'll receive after purchase-no watermarks, no demo content-just a polished, ready-to-use strategic analysis tailored for clarity and presentation.
Dogs
Legacy Health Insurance Assets
Following EverQuote's strategic exit from health insurance in late 2023, remaining legacy health assets and tail revenues sit in the BCG Matrix Dogs quadrant as low-growth, low-share operations; revenue from this segment fell to under $5m in FY2024, less than 1% of total revenue of $242m.
These assets no longer fit EverQuote's P&C focus and are clear candidates for total divestiture to stop distraction and free up resources; estimated cash return is minimal after transaction costs.
Non-Core Life Insurance Lead Gen
EverQuote's life insurance lead-gen sits in Dogs: it has under 5% estimated share of the US online life-quote market (2024 estimate) and trails auto/home segments that each drive 60-70% of revenue.
Market is crowded with specialized brokers; EverQuote's life arm often only breaks even, delivering low CAC-adjusted LTV and high churn for leads.
It consumes senior management time that could boost P&C growth, so divest or reallocate resources to higher-margin auto/home channels.
Under-65 Health Marketplace
EverQuote has deprioritized its under-65 health marketplace as it streamlines toward core verticals; like its 2024 Medicare exit, the unit lacks scale and strategic fit.
The under-65 market is fragmented and highly regulated; EverQuote holds negligible market share versus incumbents, limiting growth potential and pricing power.
Keeping these small operations ties up cash-compliance and admin costs push margins negative; in 2024 EverQuote cited similar segments as drag on adjusted EBITDA by low single-digit millions.
Traditional SEO-Driven Traffic
Traditional SEO-Driven Traffic sits in EverQuote's Dogs quadrant: historically deprioritized-leadership said they have not done much SEO traffic-and by late 2025 it was low-growth, low-share versus paid and social, contributing under 5% of site visits and ~2% of lead volume.
The channel demands high content and technical effort for uncertain returns as AI-driven search and social referrals grew 30-45% year-over-year in 2024-25, making SEO a low-return, high-cost tactic for EverQuote.
- Under 5% of site visits from organic search (late 2025)
- AI + social referrals grew 30-45% YoY (2024-25)
- High effort, uncertain ROI for EverQuote
Direct-to-Consumer Agency Model
EverQuote's shift from lead vendor to growth solutions partner makes a classic Direct-to-Consumer agency model less appealing; in 2024 EverQuote cut legacy lead-sales revenue share by ~18% as Smart Campaigns and AI referral tools took priority.
Legacy DTC agencies carry higher ops costs and lower scale versus marketplace/AI referrals-industry data show agency CAC 30-50% above programmatic referral cost per acquisition (CPA) in 2023.
As EverQuote scales Smart Campaigns and AI matching, labor-heavy lead-gen is being phased out; management noted a 2024 reduction in third-party agency spend of roughly $12M year-over-year.
- Shift reduces fixed agency overhead, boosts GMV-to-cost ratio
- AI referral models target 20-35% lower CPA
- Smart Campaigns improved lead-to-conversion by ~15% in 2024
EverQuote to divest low-return health, life & SEO units; refocus on P&C core
EverQuote's legacy health, life lead-gen, SEO traffic, and DTC agency work sit in Dogs: low growth, low share, and marginal economics-combined revenue under $5m (FY2024) vs $242m total; SEO <5% visits/~2% leads (late 2025); divest or reallocate to P&C where auto/home drive 60-70% revenue.
| Segment | 2024-25 metric | Impact |
|---|---|---|
| Legacy health | <$5m rev FY2024 | Divest |
| Life lead-gen | <5% market share | Low LTV, break-even |
| SEO | <5% visits/~2% leads | High effort, low ROI |
| DTC agency | Agency spend down $12m (2024) | Phase out |
Question Marks
AI Search and Generative AI Integration
AI search and generative AI integration at EverQuote is a Question Mark: they're entering a high-growth channel-global generative AI search ad spend rose ~120% in 2024 to an estimated $9.4B-while EverQuote's share is near zero, needing heavy R&D and marketing spend to test conversion of AI-driven traffic into high-intent insurance referrals.
Connected TV (CTV) Advertising
EverQuote is scaling Connected TV and social media to reach younger, digitally-native users, tapping a CTV market set to hit $45B US ad spend by 2025 (GroupM) and global viewers rising 18% YoY.
CTV efforts remain early-stage for EverQuote, with CTV-ad traffic contributing under 5% of paid leads in FY2024 and unit economics not yet profitable.
These are speculative, cash-consuming investments-EverQuote spent $18M on brand and new-channel marketing in 2024-so a clear scale path is required to avoid CTV becoming a Dog in the BCG matrix.
International Marketplace Expansion
International expansion for EverQuote remains a Question Mark: the global digital insurance market is projected at $62.9B in 2025 (CAGR ~13% 2020-25), but EverQuote would start from zero share and face high entry costs plus localized regulation and entrenched rivals in Europe and Asia.
New 'Smart' Insurance Products
EverQuote's new smart insurance products sit in the Question Marks quadrant: they target high-growth InsurTech niches but are early-stage and unproven for market dominance, requiring heavy customer acquisition spend to scale.
As of 2025 EverQuote reported 16% YoY growth in new product trial users and allocated ~22% of R&D and marketing budget to product launches, indicating aggressive promotion but unclear path to profitability.
- High growth niche, low current share
- Early-stage user adoption: 16% YoY (2025)
- 22% budget tilt to launches
- Needs heavy promotion and placement
Medicare Secondary Referrals
Medicare Secondary Referrals sit as Question Marks in EverQuote's BCG matrix: after exiting direct Medicare agency sales in 2024, any secondary-referral or data-monetization play in seniors insurance still lacks scale despite a 65+ US population rise of 18% from 2010-2020 and projected 20% growth by 2030 (US Census, 2024).
EverQuote's arm's-length model (launched Q2 2024) shows single-digit market share in senior-referral channels and under $5m in referral revenue in 2025, leaving ROI on data and tech spend uncertain.
These initiatives must grow to cover estimated fixed costs of ~$10-15m annually for compliant data pipelines and lead infrastructure; otherwise they risk being divestiture candidates.
- Large addressable market: 65+ segment growing ~20% by 2030
- Current traction: < $5m referral revenue in 2025
- Cost hurdle: ~$10-15m annual data/tech fixed costs
- Decision trigger: scale quickly or divest
High-growth bets (GenAI, CTV, new products, Medicare): big markets, tiny EverQuote share
Question Marks: AI search/GenAI, CTV/social, international expansion, new smart products, and Medicare secondary referrals show high growth potential but low share; 2024-25 metrics: GenAI ad spend ~$9.4B (2024), CTV US ad spend ~$45B (2025), EverQuote: <5% paid-lead CTV, $18M new-channel marketing (2024), 16% new-product trials YoY (2025), <$5M senior-referral rev (2025).
| Initiative | Growth signal | EverQuote 2024-25 |
|---|---|---|
| GenAI search | $9.4B ad spend (2024) | Near-zero share |
| CTV | $45B US ad spend (2025) | <5% paid leads |
| New products | InsurTech growth | 16% trial users YoY; 22% budget |
| Medicare referrals | 65+ pop +20% by 2030 | <$5M revenue; $10-15M fixed costs |
Frequently Asked Questions
It provides a clear, presentation-ready view of EverQuote's business mix across the four BCG quadrants. The pre-built strategic framework helps you quickly see which segments may be Stars, Cash Cows, Question Marks, or Dogs, reducing uncertainty and turning raw data into investor-ready insight.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.